within the speedily evolving area of oncology study, correct and productive mutation screening is important for building focused therapies. The KRAS products and services System plays a pivotal position On this landscape by supplying in depth solutions for KRAS mutation profiling and Evaluation. KRAS mutations, located in approximately ninety five%